Companies Dominating the Positive Allosteric Modulators Landscape
- Acadia Pharmaceuticals Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Eli Lilly and Company
- Novartis AG
- Bayer AG
- Sanofi-aventis Groupe
- Abbott Laboratories
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Siemens Healthcare GmbH
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Positive Allosteric Modulators Market size is expected to expand at significant growth rate during the forecast period i.e., between 2025-2037.
The increasing prevalence of Parkinson’s disease, schizophrenia, Alzheimer’s disease, and other mental disorder will boost the market growth.
Asia Pacific industry is likely to hold largest revenue share by 2037, on account of increasing investment in development of healthcare sector in the region, along with growing health awareness amongst the population.
The major players in the market are Eli Lilly and Company, Novartis AG, Bayer AG, Sanofi-aventis Groupe, Abbott Laboratories, Johnson & Johnson Services, Inc., Merck & Co., Inc., Siemens Healthcare GmbH, and Pfizer Inc.
